- Report
- October 2024
- 129 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- October 2024
- 149 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- September 2024
- 129 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- September 2024
- 184 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- August 2024
- 144 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- August 2024
- 177 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- July 2024
- 161 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- July 2024
- 180 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- July 2024
- 145 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- July 2024
- 151 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- July 2024
- 164 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- June 2024
- 145 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- May 2024
- 166 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1145EUR$1,250USD£973GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1374EUR$1,500USD£1,168GBP
- Report
- April 2025
- 180 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- April 2025
- 184 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- April 2025
- 180 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- April 2025
- 185 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- April 2025
- 187 Pages
Global
From €4122EUR$4,500USD£3,504GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more